User-centred Design Of A Technology-mediated, Theory Driven, Intervention Package To Reduce Incorrect Use Of Child Car Restraints
Funder
National Health and Medical Research Council
Funding Amount
$691,342.00
Summary
This project aims to develop and optimise an efficient, cost-effective intervention that provides instruction on how to correctly use child car restraints, as well as promoting behaviours required to achieve correct restraint of children in cars. This work offers potential paradigm shifting solutions to a long-standing problem that is currently putting more than 50% of children travelling in cars at a three-fold increased risk of serious injury and death
Harnessing Neural Plasticity To Improve Functional Outcomes Following Burn Injury.
Funder
National Health and Medical Research Council
Funding Amount
$667,984.00
Summary
Burn is painful and leads to long-term functional impairment and increased chronic disease. Pain and peripheral injury induce changes in the brain that can be functionally beneficial or maladaptive, yet we know little about brain changes following burn injury. This project will identify the mechanisms and functional impact of neural plasticity after burn injury, and test the efficacy of a neural intervention to reduce pain and improve functional recovery following burn injury.
Spinosyns As Endectocides For Blocking Transmission Of Malaria And Other Mosquito-borne Diseases
Funder
National Health and Medical Research Council
Funding Amount
$758,299.00
Summary
Malaria is a disease caused by a parasite. It is transmitted by mosquitoes and kills 400,000 people annually. To prevent malaria we must stop transmission. We have discovered a natural substance that, if ingested, makes an animal's blood lethal to at least one type of mosquito. It also kills the parasite. We aim to determine if it kills other key mosquito types and how it kills the parasite. We expect this study will lead to a pill that stops transmission of malaria and other tropical diseases.
Serum Neurofilament Light As A Biomarker To Improve Management Of Mild Traumatic Brain Injuries
Funder
National Health and Medical Research Council
Funding Amount
$1,092,781.00
Summary
There is increasing awareness that mild traumatic brain injuries (mTBIs), such as concussions, can lead to persistent or permanent neurological symptoms. Nonetheless, the identification and management of mTBIs remains notoriously difficult. In this proposal, we will assess exactly how a novel blood test can be implemented to assist in mTBI diagnosis, and the identification and management of individuals at risk of suffering persistent or chronic neurological problems.
BETTER MAN Project: Tailored Early Online Intervention For Men Using Intimate Partner Violence
Funder
National Health and Medical Research Council
Funding Amount
$506,202.00
Summary
Domestic violence damages the health of families, particularly women and children. We aim to make all families safer by generating new knowledge from a world-first trial of a healthy relationship website (BETTER MAN). This website assists men to identify their use of abuse and violence early and motivate them to seek help. We will tailor their help-seeking response to their individual experiences. We will have the safety, health, and well-being of women and children as our focus in this work.
Facial paralysis results in loss of the ability to blink, which is the primary means of protecting and lubricating the eye. The eye becomes dry and ulcerated and eventually vision loss ensues. No therapy exists that can reliably restore blink and hence treatment is mostly palliative today. BLINC is an implantable device that artificially restores eye closure. It is wirelessly powered and readily implantable. BLINC has achieved eye closure similar to natural blinking in human cadaveric models.
A Wireless Electric Nerve-guide For Peripheral Nerve Repair
Funder
National Health and Medical Research Council
Funding Amount
$805,064.00
Summary
We aim to deliver a radical new precision intervention for peripheral nerve repair to improve the lives of people with peripheral nerve damage. Drawing from our recently awarded work on 'electric neural tissue engineering', we will pre-clinically test our invention of a unique clinically-amenable electric nerve-guide (e-nerve-guide), designed to act as a protective nerve conduit and wirelessly electrically-stimulate damaged nerves for their regeneration and restoration of function.
Preservation And Generation Of Beta Cells In Type 1 Diabetes With Novel Mimetic Peptides
Funder
National Health and Medical Research Council
Funding Amount
$1,096,055.00
Summary
Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin producing beta cells in the pancreas. It can cause heart and kidney disease, and nerve damage. T1D is treated with insulin injections that can cause life-threatening low blood sugar levels. We have developed a new treatment that may stop beta cell loss, generate new beta cells and remove the need for insulin injections in T1D patients. A positive outcome will identify a completely new T1D treatment option.
Improving Clinical Outcomes Of Antimicrobial Resistant Infections With A Drug-free Intervention
Funder
National Health and Medical Research Council
Funding Amount
$999,581.00
Summary
Superbugs, or antimicrobial-resistant pathogens, cause recurring infections and non-healing wounds after surgery as existing therapies fail to effectively kill them. We will develop a medical device to fight superbugs with UV light that is effective against bacteria and fungi without causing harm to human cells. This could eradicate superbugs at infection sites, aid wound healing and actively improve health outcomes after surgery.
Development Of Novel Anti-malaria Drugs That Block Parasite Invasion
Funder
National Health and Medical Research Council
Funding Amount
$1,035,623.00
Summary
Malaria is a devastating parasitic disease that kills over 400,000 people a year. Antimalarial drugs play a crucial role in helping eradicate malaria but of great concern is that parasites are becoming resistant to current drugs. We are developing drugs that prevent parasites from invading and proliferating in human blood which causes malaria. We are also discovering how the drugs work with the aim of greatly improving their performance towards clinical uptake.